Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
The latest update is out from TC Biopharm (Holdings) Plc Sponsored ADR ( (TCBP) ).
TC BioPharm (Holdings) plc has announced a General Meeting scheduled for December 30, 2024, where shareholders will consider key resolutions. These include authorizing directors to capitalize share premium and allot new shares, with implications for company growth and shareholder value. In addition, a special resolution seeks to empower directors to allot equity securities without pre-emption rights, potentially enhancing the company’s capital-raising flexibility. The Board recommends voting in favor, indicating confidence in the resolutions’ benefits for the company and stakeholders.
More about TC Biopharm (Holdings) Plc Sponsored ADR
YTD Price Performance: -98.33%
Average Trading Volume: 1,168,024
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $261.6K
For an in-depth examination of TCBP stock, go to TipRanks’ Stock Analysis page.
